Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study).
Silje Watterdal SyversenGuro L GollKristin K JørgensenInge C OlsenØystein SandangerJohanna E GehinDavid J WarrenJoseph SextonCato MørkJørgen JahnsenTore K KvienNils BolstadEspen A HaavardsholmPublished in: Trials (2020)
Clinicaltrials.gov, NCT03074656. Registered on 090317.